PRLR regulates hepatic insulin sensitivity in mice via STAT5

Junjie Yu1, Fei Xiao, Qian Zhang

  • 1Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, the Graduate School of the Chinese Academy of Sciences, Shanghai, People's Republic of China.

Diabetes
|June 19, 2013
PubMed

Insights

This study reveals that the prolactin receptor (PRLR) plays a crucial role in regulating insulin sensitivity. Modulating PRLR levels impacts metabolic health, offering new insights into insulin resistance mechanisms.

Area of Science:

  • Metabolic disease research
  • Endocrinology
  • Molecular biology

Background:

  • Insulin resistance is a key factor in metabolic diseases, but its mechanisms are not fully understood.
  • The prolactin receptor (PRLR) has known functions, but its direct impact on insulin sensitivity was unexplored.

Purpose of the Study:

  • To investigate the role of the prolactin receptor (PRLR) in regulating insulin sensitivity.
  • To elucidate the molecular mechanisms underlying PRLR's effect on insulin sensitivity.

Main Methods:

  • In vivo studies using adenovirus to overexpress or knock down PRLR in mice.
  • In vitro experiments to assess PRLR's effect on insulin sensitivity.
  • Analysis of the signal transducer and activator of transcription-5 (STAT5) pathway.
  • Examination of PRLR expression in insulin-resistant (db/db mice) and insulin-sensitive (leucine deprivation) models.
  • Investigation of the GCN2/mTOR/S6K1 pathway in regulating PRLR expression.

Main Results:

  • Overexpression of PRLR improved insulin sensitivity, while knockdown impaired it in mouse models and in vitro.
  • The STAT5 pathway is essential for PRLR-mediated regulation of insulin sensitivity.
  • PRLR expression inversely correlated with insulin resistance, decreasing in db/db mice and increasing with leucine deprivation.
  • Altering PRLR levels reversed insulin sensitivity in both resistant and sensitive conditions.
  • Leucine deprivation increased hepatic PRLR expression via the GCN2/mTOR/S6K1 pathway.

Conclusions:

  • Hepatic PRLR has a novel function in regulating insulin sensitivity.
  • PRLR expression is subject to nutritional regulation, impacting metabolic homeostasis.
  • These findings offer new therapeutic targets for metabolic diseases related to insulin resistance.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...